Story
TD Cowen: US Diesel Export Quota Seen as More Likely Than Full Ban

Summary
A diesel export quota is a more plausible U.S. policy response to high fuel prices than an outright ban, according to TD Cowen, which notes such a move could significantly lower domestic prices and impact refiner margins.
A U.S. diesel export quota appears more likely than a complete ban on oil or product exports, though any such controls remain unlikely in the near term, according to a research note from TD Cowen. The firm stated that investor attention is increasingly focused on potential government restrictions as diesel prices reach record levels ahead of the November 3, 2026, midterm elections.
Potential Market Impact
TD Cowen's analysis suggests that a temporary, two-month export quota could push domestic diesel prices down by approximately $16 per barrel and reduce refining margins by $11 per barrel. Analyst Jason Gabelman noted prices could fall further as inventories build, potentially finding a floor near gasoline prices as refiners shift production away from diesel. Currently, spot diesel prices are trading at a significant premium of $60 per barrel above gasoline.
Specific companies could see varied exposure to such a policy. According to the firm, the refiners most at risk include:
- PBF Energy (PBF) and Delek US Holdings (DK), due to their large U.S. mainland presence.
- BP could face the largest headwinds among international oil companies because of its U.S. refinery footprint.
- Par Pacific Holdings (PARR) and Phillips 66 (PSX) are expected to see a more limited impact.
- TotalEnergies (TTE) could potentially experience a net benefit.
AdPolicy Rationale and Context
The U.S. currently exports 1.6 million barrels per day (bpd) of diesel, which is 300,000 bpd above historical norms, while importing about 180,000 bpd, primarily to the East Coast. TD Cowen calculates that a quota set roughly 200,000 bpd below current export levels could eliminate the need for U.S. diesel imports and effectively disconnect domestic prices from more expensive global markets.
However, the firm's Washington Research Group analyst, John Miller, indicated that the Trump Administration’s policy preference leans toward boosting supply through measures like Strategic Petroleum Reserve exchanges and regulatory waivers. Any export control measure would most likely be a time-limited action designed to provide political cover while minimizing long-term market distortions, the firm concluded.
Read next
More on Stocks
AI Infrastructure Firm Accelevation Sets IPO Terms, Targeting Up to $5.4 Billion Valuation
AI infrastructure provider Accelevation is targeting a valuation of up to $5.37 billion and aims to raise as much as $720 million in its upcoming U.S. initial public offering, capitalizing on strong investor interest in artificial intelligence.

Quest, Labcorp Shares Tumble on Proposed Medicare Reimbursement Cuts
Shares of Quest Diagnostics and Labcorp fell sharply in premarket trading after the Centers for Medicare & Medicaid Services proposed significant cuts to laboratory testing fees, set to begin in 2027.

Roche's Obesity Drug Enicepatide Shows 15.5% Weight Loss in Mid-Stage Diabetes Trial
Swiss drugmaker Roche announced its experimental obesity drug, enicepatide, helped patients with type 2 diabetes achieve an average 15.5% weight loss and significant blood sugar control in a mid-stage study.

DoorDash to Pay $131.5 Million in NYC Settlement Over Worker Pay Issues
Food delivery giant DoorDash has agreed to a $131.5 million settlement with New York City following a probe that found the company underpaid or delayed payments to its delivery workers.